Experience of Cancer Research Center in the treatment of advanced germ cell tumors

Cover Page

Cite item

Full Text

Abstract

The experience of CRC in the treatment of advanced germ cell tumors is reported. The analysis of factors influencing prognosis and treatment tactics is carried out. Contemporary conception of advanced germ cell tumors treatment implies the initial use of platinum based chemotherapy. After completion of chemotherapy, surgical removal of residual tumor (retroperitoneal and mediastinal lymph nodes, lung and liver metastases) carries diagnostic and curative means. Such approach allows curing 50-90% of patients depending on prognostic factors. Results of induction chemotherapy for relapses of germ cell tumors are presented separately. Treatment of this condition comprises chemotherapy with inclusion of ifosfamid or taxanes with following cytoreductive surgery. This modality allows long term remission in the fourth of patients with relapse of germ cell tumors.

About the authors

S. A. Tyulyandin

ГУ РОНЦ им. Н.Н. Блохина РАМН

Author for correspondence.
Russian Federation

A. A. Tryakin

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

A. A. Bulanov

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

K. M. Figurin

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

I. A. Fainshtein

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

B. E. Polotskiy

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

A. V. Mitin

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

T. I. Zaharova

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

A. M. Garin

ГУ РОНЦ им. Н.Н. Блохина РАМН

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.